Literature DB >> 29564184

How does the tumor microenvironment play a role in hepatobiliary tumors?

Fathima Kamil1, Julie H Rowe2.   

Abstract

The tumor microenvironment (TME) is defined as the structural and dynamic network of cellular and non-cellular interactions between malignant cells and the surrounding non-malignant matrix. Hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) are two of the most challenging gastrointestinal malignancies. Despite clinical advancements in understanding tumor biology and growth of the chemotherapeutic industry, there have been no corresponding improvements in prognosis and overall survival of HCC and PDAC. Both of these cancers have a very intimate relationship with their surrounding environment; the TME is thought to actively participate in initiating and sustaining these malignancies. Individual TME constituents play a vital role in chemoresistance and recurrence after surgery and have been established as independent prognostic factors. This review article will highlight the diverse structural components, key signaling pathways, and extracellular matrices of HCC and PDAC and discuss their crosstalk with tumor cells to promote growth and metastasis. The article will also summarize the latest laboratory and clinical research based on therapeutic targets identified within the TME of both HCC and PDAC.

Entities:  

Keywords:  Tumor microenvironment (TME); hepatobiliary cancer, pancreatic ductal adenocarcinoma (PDAC); hepatocellular carcinoma (HCC)

Year:  2018        PMID: 29564184      PMCID: PMC5848044          DOI: 10.21037/jgo.2017.06.09

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  96 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

2.  IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.

Authors:  Yuliya Pylayeva-Gupta; Shipra Das; Jesse S Handler; Cristina H Hajdu; Maryaline Coffre; Sergei B Koralov; Dafna Bar-Sagi
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

3.  Hedgehog inhibitor decreases chemosensitivity to 5-fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer.

Authors:  Hideya Onishi; Yoshihiro Morifuji; Masaya Kai; Kumi Suyama; Hironori Iwasaki; Mitsuo Katano
Journal:  Cancer Sci       Date:  2012-05-17       Impact factor: 6.716

4.  Substrate stiffness promotes latent TGF-β1 activation in hepatocellular carcinoma.

Authors:  Mingshu Pang; Yao Teng; Jianyong Huang; Yuan Yuan; Feng Lin; Chunyang Xiong
Journal:  Biochem Biophys Res Commun       Date:  2016-12-24       Impact factor: 3.575

5.  Cancer-Associated Fibroblasts Regulate Tumor-Initiating Cell Plasticity in Hepatocellular Carcinoma through c-Met/FRA1/HEY1 Signaling.

Authors:  Eunice Yuen Ting Lau; Jessica Lo; Bowie Yik Ling Cheng; Mark Kin Fai Ma; Joyce Man Fong Lee; Johnson Kai Yu Ng; Stella Chai; Chi Ho Lin; Suk Ying Tsang; Stephanie Ma; Irene Oi Lin Ng; Terence Kin Wah Lee
Journal:  Cell Rep       Date:  2016-04-28       Impact factor: 9.423

6.  Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients.

Authors:  Maria Serova; Annemilaï Tijeras-Raballand; Célia Dos Santos; Miguel Albuquerque; Valerie Paradis; Cindy Neuzillet; Karim A Benhadji; Eric Raymond; Sandrine Faivre; Armand de Gramont
Journal:  Oncotarget       Date:  2015-08-28

7.  A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer.

Authors:  Nobuaki Suzuki; Shoichi Hazama; Tomio Ueno; Hiroto Matsui; Yoshitaro Shindo; Michihisa Iida; Kiyoshi Yoshimura; Shigefumi Yoshino; Kazuyoshi Takeda; Masaaki Oka
Journal:  J Immunother       Date:  2014-01       Impact factor: 4.456

8.  Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients.

Authors:  Xiaobin Gu; Xian-Shu Gao; Wei Xiong; Wei Guo; Linjun Han; Yun Bai; Chuan Peng; Ming Cui; Mu Xie
Journal:  Onco Targets Ther       Date:  2016-08-02       Impact factor: 4.147

9.  EpCAM+ Liver Cancer Stem-Like Cells Exhibiting Autocrine Wnt Signaling Potentially Originate in Cirrhotic Patients.

Authors:  Ritu Khosla; Archana Rastogi; Gayatri Ramakrishna; Viniyendra Pamecha; Ashok Mukhopadhyay; Madavan Vasudevan; Shiv Kumar Sarin; Nirupma Trehanpati
Journal:  Stem Cells Transl Med       Date:  2017-01-18       Impact factor: 6.940

10.  Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy.

Authors:  Hong Jiang; Samarth Hegde; Brett L Knolhoff; Yu Zhu; John M Herndon; Melissa A Meyer; Timothy M Nywening; William G Hawkins; Irina M Shapiro; David T Weaver; Jonathan A Pachter; Andrea Wang-Gillam; David G DeNardo
Journal:  Nat Med       Date:  2016-07-04       Impact factor: 53.440

View more
  9 in total

1.  [Expression and clinical significance of chemokine CXCL10 and its receptor CXCR3 in hepatocellular carcinoma].

Authors:  J Zhang; J Chen; G W Guan; T Zhang; F M Lu; X M Chen
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-18

Review 2.  Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment.

Authors:  Lihong Wang; Louisa S Chard Dunmall; Zhenguo Cheng; Yaohe Wang
Journal:  J Immunother Cancer       Date:  2022-05       Impact factor: 12.469

3.  Elevated N-methyltransferase expression induced by hepatic stellate cells contributes to the metastasis of hepatocellular carcinoma via regulation of the CD44v3 isoform.

Authors:  Jie Li; Song You; Sheng Zhang; Qing Hu; Fuqiang Wang; Xiaoqin Chi; Wenxiu Zhao; Chengrong Xie; Changmao Zhang; Yaqi Yu; Jianmin Liu; Yue Zhao; Pingguo Liu; Yi Zhang; Xujin Wei; Qiu Li; Xiaomin Wang; Zhenyu Yin
Journal:  Mol Oncol       Date:  2019-07-11       Impact factor: 6.603

4.  Macrovascular Endothelial Cells Enhance the Motility of Liver Cancer Cells by Up-regulation of MMP-3, Activation of Integrin/FAK Signaling Pathway and Induction of Non-classical Epithelial-mesenchymal Transition.

Authors:  Song-Ming Ding; Ai-Li Lu; Jian-Fang Lu; Xu-Liang Chen; Muhammad Ibrahim Alhadi Edoo; Lin Zhou; Hai-Yang Xie; Shu-Sen Zheng; Qi-Yong Li
Journal:  J Cancer       Date:  2020-02-03       Impact factor: 4.207

5.  Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma.

Authors:  Junyu Huo; Liqun Wu; Yunjin Zang; Hongjing Dong; Xiaoqiang Liu; Fu He; Xiao Zhang
Journal:  BMC Cancer       Date:  2021-01-07       Impact factor: 4.430

6.  Comprehensive Characterization of Immunological Profiles and Clinical Significance in Hepatocellular Carcinoma.

Authors:  Ping Tao; Liang Hong; Wenqing Tang; Qun Lu; Yanrong Zhao; Si Zhang; Lijie Ma; Ruyi Xue
Journal:  Front Oncol       Date:  2021-01-22       Impact factor: 6.244

7.  Identification of Gene-Set Signature in Early-Stage Hepatocellular Carcinoma and Relevant Immune Characteristics.

Authors:  Qijie Zhao; Rawiwan Wongpoomchai; Arpamas Chariyakornkul; Zhangang Xiao; Chalermchai Pilapong
Journal:  Front Oncol       Date:  2021-10-22       Impact factor: 6.244

8.  Diagnosis System of Microscopic Hyperspectral Image of Hepatobiliary Tumors Based on Convolutional Neural Network.

Authors:  Shixin Huang; Jiawei Luo; Kexue Pu; Min Wu
Journal:  Comput Intell Neurosci       Date:  2022-03-17

Review 9.  Macrophage-derived extracellular vesicles: diverse mediators of pathology and therapeutics in multiple diseases.

Authors:  Yizhuo Wang; Meng Zhao; Shuyun Liu; Jun Guo; Yanrong Lu; Jingqiu Cheng; Jingping Liu
Journal:  Cell Death Dis       Date:  2020-10-28       Impact factor: 8.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.